Category: Science blog September 17, 2018 0 comments
Meg and Beth share the story of their younger sister Eve, who was diagnosed with Ewing’s Sarcoma – a type of bone cancer – in July 2015.
Category: Science blog September 15, 2018 0 comments
In the news this week: New global cancer figures revealed and a study sheds new light on which faults in the BRCA1 gene could increase cancer risk.
Category: Science blog September 14, 2018 1 comment
Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder.
Category: Science blog September 13, 2018 0 comments
Ahead of this year’s political party conferences, we asked MPs to outline their ambitions for the NHS and cancer prevention, diagnosis and treatment.
Category: Science blog September 8, 2018 0 comments
In the news this week: NHS will fund personalised cell therapy for some children with blood cancer and bowel cancer screening uptake is dropping.
Category: Science blog September 5, 2018 2 comments
We’re launching a new Children’s Brain Tumour Centre of Excellence to speed up the discovery of new treatments for children with brain tumours.
Category: Science blog September 1, 2018 1 comment
In the news this week: engineered cell therapy given initial ‘no’ for NHS in England and we publish our research highlights in our 2017/18 annual review.
Category: Science blog August 31, 2018 1 comment
Our researchers are working on a new way to improve chemotherapy treatment for aggressive brain tumours, using the precious metal palladium.
Category: Science blog August 30, 2018 1 comment
The Government have published the first in a series of plans in the event of a ‘no-deal’ Brexit. But how will this affect cancer patients and research?
Category: Science blog August 29, 2018 1 comment
As part of our Annual Review 2017/18, our outgoing CEO, Sir Harpal Kumar, shares how our knowledge of cancer has changed in the last 15 years.
Text from Cancer Research UK Science blog by Cancer Research UK, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License.
